These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 18797268)

  • 21. Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents.
    Rapkin AJ; Mikacich JA
    Paediatr Drugs; 2013 Jun; 15(3):191-202. PubMed ID: 23529867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Premenstrual exacerbations of mood disorders.
    Miller MN; Miller BE
    Psychopharmacol Bull; 2001; 35(3):135-49. PubMed ID: 12397883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treating premenstrual dysphoric disorder using serotonin agents.
    Lin J; Thompson DS
    J Womens Health Gend Based Med; 2001 Oct; 10(8):745-50. PubMed ID: 11703886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. History, evolution, and diagnosis of premenstrual dysphoric disorder.
    Endicott J
    J Clin Psychiatry; 2000; 61 Suppl 12():5-8. PubMed ID: 11041378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Premenstrual syndrome (PMS) in adolescents: severity and impairment.
    Vichnin M; Freeman EW; Lin H; Hillman J; Bui S
    J Pediatr Adolesc Gynecol; 2006 Dec; 19(6):397-402. PubMed ID: 17174829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Premenstrual dysphoric disorder and psychiatric co-morbidity.
    Kim DR; Gyulai L; Freeman EW; Morrison MF; Baldassano C; Dubé B
    Arch Womens Ment Health; 2004 Feb; 7(1):37-47. PubMed ID: 14963731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychological aspects of premenstrual syndrome.
    Indusekhar R; Usman SB; O'Brien S
    Best Pract Res Clin Obstet Gynaecol; 2007 Apr; 21(2):207-20. PubMed ID: 17175199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder.
    Segebladh B; Borgström A; Nyberg S; Bixo M; Sundström-Poromaa I
    Am J Obstet Gynecol; 2009 Aug; 201(2):139.e1-8. PubMed ID: 19398092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation and management of premenstrual syndrome and premenstrual dysphoric disorder.
    Frackiewicz EJ; Shiovitz TM
    J Am Pharm Assoc (Wash); 2001; 41(3):437-47. PubMed ID: 11372908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The premenstrual syndrome revisited.
    Campagne DM; Campagne G
    Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):4-17. PubMed ID: 16916572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Premenstrual dysphoric disorder: diagnostic and therapeutic approach].
    Guedj F
    Rev Prat; 1997 Nov; 47(17):1907-12. PubMed ID: 9453190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Premenstrual disorders: epidemiology and disease burden.
    Mishell DR
    Am J Manag Care; 2005 Dec; 11(16 Suppl):S473-9. PubMed ID: 16336056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Approach to premenstrual dysphoria for the mental health practitioner.
    Vigod SN; Frey BN; Soares CN; Steiner M
    Psychiatr Clin North Am; 2010 Jun; 33(2):257-72. PubMed ID: 20385336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders.
    Rapkin AJ; Mikacich JA; Moatakef-Imani B; Rasgon N
    Curr Psychiatry Rep; 2002 Dec; 4(6):419-28. PubMed ID: 12441021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comorbidity in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing.
    Teesson M; Slade T; Mills K
    Aust N Z J Psychiatry; 2009 Jul; 43(7):606-14. PubMed ID: 19530017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between seasonal and premenstrual symptoms is continuous and is not fully accounted for by depressive symptoms.
    Portella AT; Haaga DA; Rohan KJ
    J Nerv Ment Dis; 2006 Nov; 194(11):833-7. PubMed ID: 17102707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of premenstrual symptoms and disorders.
    Dennerstein L; Lehert P; Heinemann K
    Menopause Int; 2012 Jun; 18(2):48-51. PubMed ID: 22611221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of beneficial effects of clonidine in the treatment of premenstrual dysphoric disorder: results of a double-blind, randomized study.
    Bunevicius R; Hinderliter AL; Light KC; Pedersen CA; Girdler SS
    Hum Psychopharmacol; 2005 Jan; 20(1):33-9. PubMed ID: 15536640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Premenstrual syndrome and dysphoric premenstrual syndrome].
    Alba P; Rodríguez C
    Vertex; 2014; 25(117):370-6. PubMed ID: 25545084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of mood and anxiety disorders in women who seek treatment for premenstrual syndrome.
    Bailey JW; Cohen LS
    J Womens Health Gend Based Med; 1999 Nov; 8(9):1181-4. PubMed ID: 10595331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.